Astellas announces wind-down of Agensys research operations
Astellas Pharma announced that it is winding down its Agensys research operations in Santa Monica, California, USA, to further refine its oncology strategy by expanding its investment in the research in new technologies and modalities and reducing its focus on Antibody-Drug Conjugate research. July 26, 2017